TITLE

Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives

AUTHOR(S)
Chow, Maggie Zi; Boheler, Kenneth R.; Li, Ronald A.
PUB. DATE
September 2013
SOURCE
Stem Cell Research & Therapy;2013, Vol. 4 Issue 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Heart diseases remain a major cause of mortality and morbidity worldwide. However, terminally differentiated human adult cardiomyocytes (CMs) possess a very limited innate ability to regenerate. Directed differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into CMs has enabled clinicians and researchers to pursue the novel therapeutic paradigm of cell-based cardiac regeneration. In addition to tissue engineering and transplantation studies, the need for functional CMs has also prompted researchers to explore molecular pathways and develop strategies to improve the quality, purity and quantity of hESC-derived and iPSC-derived CMs. In this review, we describe various approaches in directed CM differentiation and driven maturation, and discuss potential limitations associated with hESCs and iPSCs, with an emphasis on the role of epigenetic regulation and chromatin remodeling, in the context of the potential and challenges of using hESC-CMs and iPSC-CMs for drug discovery and toxicity screening, disease modeling, and clinical applications.
ACCESSION #
90275608

 

Related Articles

  • Strategies for enrichment and selection of stem cell-derived tissue precursors. Bernstein, Harold S.; Hyun, William C. // Stem Cell Research & Therapy;2012, Vol. 3 Issue 3, p1 

    Human embryonic stem cells have the capacity for self-renewal and pluripotency and thus are a primary candidate for tissue engineering and regenerative therapies. These cells also provide an opportunity to study the development of human tissues ex vivo. To date, numerous human embryonic stem...

  • Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy -- The Turning Point of Cell-Based Regenerative Medicine. Parsons, Xuejun H. // British Biotechnology Journal;Oct-Dec2013, Vol. 3 Issue 4, p424 

    To date, the lack of a clinically-suitable source of engraftable human stem/progenitor cells with adequate neurogenic potential has been the major setback in developing safe and effective cell-based therapies for regenerating the damaged or lost CNS structure and circuitry in a wide range of...

  • Tracking the mechanical dynamics of human embryonic stem cell chromatin. Hinde, Elizabeth; Cardarelli, Francesco; Chen, Aaron; Khine, Michelle; Gratton, Enrico // Epigenetics & Chromatin;2012, Vol. 5 Issue 1, p1 

    Background: A plastic chromatin structure has emerged as fundamental to the self-renewal and pluripotent capacity of embryonic stem (ES) cells. Direct measurement of chromatin dynamics in vivo is, however, challenging as high spatiotemporal resolution is required. Here, we present a new...

  • A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Später, Daniela; Abramczuk, Monika K.; Buac, Kristina; Zangi, Lior; Stachel, Maxine W.; Clarke, Jonathan; Sahara, Makoto; Ludwig, Andreas; Chien, Kenneth R. // Nature Cell Biology;Sep2013, Vol. 15 Issue 9, p1098 

    Most of the mammalian heart is formed from mesodermal progenitors in the first and second heart fields (FHF and SHF), whereby the FHF gives rise to the left ventricle and parts of the atria and the SHF to the right ventricle, outflow tract and parts of the atria. Whereas SHF progenitors have...

  • Genetic and epigenetic stability of human pluripotent stem cells. Lund, Riikka J.; Närvä, Elisa; Lahesmaa, Riitta // Nature Reviews Genetics;Oct2012, Vol. 13 Issue 10, p732 

    Studies using high-resolution genome-wide approaches have recently reported that genomic and epigenomic alterations frequently accumulate in human pluripotent cells. Detailed characterization of these changes is crucial for understanding the impact of these alterations on self-renewal and...

  • Tracing the genesis of human embryonic stem cells. Pribluda, Ariel; Hanna, Jacob H // Nature Biotechnology;Mar2012, Vol. 30 Issue 3, p247 

    The article discusses the potential of the human embryonic stem cells (hESC) in the area of regenerative medicine and disease modeling. It cites the study which showed that pluripotent cells of the blastocyst inner cell mass (ICM) undergo significant molecular and epigenetic changes during the...

  • One-Step Derivation of Mesenchymal Stem Cell (MSC)-Like Cells from Human Pluripotent Stem Cells on a Fibrillar Collagen Coating. Liu, Yongxing; Goldberg, A. Jon; Dennis, James E.; Gronowicz, Gloria A.; Kuhn, Liisa T. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Controlled differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into cells that resemble adult mesenchymal stem cells (MSCs) is an attractive approach to obtain a readily available source of progenitor cells for tissue engineering. The present study...

  • Production of Human Pluripotent Stem Cell Therapeutics under Defined Xeno-free Conditions: Progress and Challenges. Fan, Yongjia; Wu, Jincheng; Ashok, Preeti; Hsiung, Michael; Tzanakakis, Emmanuel // Stem Cell Reviews & Reports;Feb2015, Vol. 11 Issue 1, p96 

    Recent advances on human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) have brought us closer to the realization of their clinical potential. Nonetheless, tissue engineering and regenerative medicine applications will...

  • One-Step Derivation of Mesenchymal Stem Cell (MSC)-Like Cells from Human Pluripotent Stem Cells on a Fibrillar Collagen Coating. Liu, Yongxing; Goldberg, A. Jon; Dennis, James E.; Gronowicz, Gloria A.; Kuhn, Liisa T. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Controlled differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into cells that resemble adult mesenchymal stem cells (MSCs) is an attractive approach to obtain a readily available source of progenitor cells for tissue engineering. The present study...

Share

Read the Article

Courtesy of MICHIGAN ELIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics